🎉 M&A multiples are live!
Check it out!

Liquidia Valuation Multiples

Discover revenue and EBITDA valuation multiples for Liquidia and similar public comparables like Vivoryon Therapeutics, Galapagos, and Julphar.

Liquidia Overview

About Liquidia

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.


Founded

2004

HQ

United States of America
Employees

170

Website

liquidia.com

Financials

LTM Revenue $22.5M

LTM EBITDA n/a

EV

$1.1B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Liquidia Financials

Liquidia has a last 12-month revenue of $22.5M and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Liquidia achieved revenue of $14.0M and an EBITDA of -$116M.

Liquidia expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Liquidia valuation multiples based on analyst estimates

Liquidia P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $17.5M $14.0M XXX XXX XXX
Gross Profit $13.1M $14.6M XXX XXX XXX
Gross Margin 75% 104% XXX XXX XXX
EBITDA -$70.1M -$116M XXX XXX XXX
EBITDA Margin -401% -827% XXX XXX XXX
Net Profit -$41.0M -$78.5M XXX XXX XXX
Net Margin -235% -561% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Liquidia Stock Performance

As of April 15, 2025, Liquidia's stock price is $14.

Liquidia has current market cap of $1.2B, and EV of $1.1B.

See Liquidia trading valuation data

Liquidia Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.1B $1.2B XXX XXX XXX XXX $-1.63

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Liquidia Valuation Multiples

As of April 15, 2025, Liquidia has market cap of $1.2B and EV of $1.1B.

Liquidia's trades at 50.0x LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Liquidia's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Liquidia and 10K+ public comps

Liquidia Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.1B XXX XXX XXX
EV/Revenue 80.4x XXX XXX XXX
EV/EBITDA -9.7x XXX XXX XXX
P/E -9.0x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -11.0x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Liquidia Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Liquidia Valuation Multiples

Liquidia's NTM/LTM revenue growth is 261%

Liquidia's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.8M for the same period.

Over next 12 months, Liquidia's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Liquidia's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Liquidia and other 10K+ public comps

Liquidia Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -20% XXX XXX XXX XXX
EBITDA Margin -827% XXX XXX XXX XXX
EBITDA Growth 65% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -566% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $0.8M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 583% XXX XXX XXX XXX
R&D Expenses to Revenue 342% XXX XXX XXX XXX
Opex to Revenue 925% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Liquidia Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Drug Delivery Systems comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Liquidia M&A and Investment Activity

Liquidia acquired  XXX companies to date.

Last acquisition by Liquidia was  XXXXXXXX, XXXXX XXXXX XXXXXX . Liquidia acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Liquidia

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Liquidia

When was Liquidia founded? Liquidia was founded in 2004.
Where is Liquidia headquartered? Liquidia is headquartered in United States of America.
How many employees does Liquidia have? As of today, Liquidia has 170 employees.
Who is the CEO of Liquidia? Liquidia's CEO is Dr. Roger A. Jeffs, PhD.
Is Liquidia publicy listed? Yes, Liquidia is a public company listed on NAS.
What is the stock symbol of Liquidia? Liquidia trades under LQDA ticker.
When did Liquidia go public? Liquidia went public in 2018.
Who are competitors of Liquidia? Similar companies to Liquidia include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Liquidia? Liquidia's current market cap is $1.2B
What is the current revenue of Liquidia? Liquidia's last 12-month revenue is $22.5M.
What is the current EV/Revenue multiple of Liquidia? Current revenue multiple of Liquidia is 50.0x.
What is the current revenue growth of Liquidia? Liquidia revenue growth between 2023 and 2024 was -20%.
Is Liquidia profitable? Yes, Liquidia is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.